$BFLY

Caezza Nicholas sold $14K of BFLY

Caezza Nicholas (Deputy General Counsel) sold 1,709 shares of Butterfly Network, Inc. (BFLY) at $8.15 on 2026-09-02.

Original reporting
SEC EDGAR · Caezza Nicholas
Published Sep 4, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BFLY
Neutral
high confidence
Mentioned
$BFLY
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

The sale is modest and unlikely to affect market perception of Butterfly Network.

02

Market read

A routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming legal matters or compensation adjustments not disclosed.

Relevance 3/10Novelty 3/10Timing: post‑market filing on 2026‑09‑02

Background

Form 4 filings disclose insider trades; investors monitor them for signals of insider confidence.

Company-level read

Ticker impact

$BFLYNeutralHigh confidence
Context

Deputy General Counsel Caezza Nicholas sold 1,709 shares for $13,926.64 on 2026-09-02, reducing his holdings to 305,166 shares.

Expected impact

Limited short-term impact; likely negligible price movement.

Evidence & confidence

The transaction size is small relative to float and does not signal material insider sentiment.

Market effects

No broader sector impact; isolated insider transaction.

None

None

Counterpoint

The sell could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Butterfly Network, Inc.

    Medical imaging device maker listed on Nasdaq (BFLY).

  • Caezza Nicholas

    Deputy General Counsel and insider officer at Butterfly Network.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

$BFLYMedAI 9/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network (BFLY) reported Q2 2026 revenue of $32.6M, up 39% y/y, driven by Embedded revenue of $10.8M (+439%). Gross profit rose to $23.3M and gross margin to 71%. Adjusted EBITDA loss narrowed to $1.4M. Q3 revenue guidance is $26M to $30M, and FY2026 revenue guidance is $119M to $123M.

$BFLYMedAI 8/10

Butterfly Network, Inc. Q2 2026 Earnings Call Summary

Butterfly Network, Inc. reported Q2 2026 progress driven by POCUS, Home and Community Care, and Embedded partnerships. Embedded revenue rose 439% on the Midjourney partnership. Gross margin was 71%. Full-year 2026 revenue guidance was raised to $119 million-$123 million. Home and Community Care first commercial implementation starts Oct 1, with revenue in Q4 2026.